Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study examined women's experiences with baldness due to conditions like alopecia and monilethrix, highlighting how they navigate femininity and societal assumptions about illness.

Some men can have female pattern baldness without hormonal abnormalities or signs of feminization.

This study found that women with female pattern hair loss had significant hormonal imbalances, specifically involving adrenal androgens, suggesting these may play a central role in the condition's development.

This study reported that in women with pattern baldness, hormonal levels and iron deficiency were significantly associated with the condition, but trichoscopic findings were similar across different forms of female pattern hair loss.

This study found that women with female pattern baldness often had a higher ratio of 3 alpha,17 beta-androstanediol glucuronide to sex hormone-binding globulin and lower serum sex hormone-binding globulin, possibly indicating minimal androgen excess.

This review discusses the classification of female androgenic alopecia using the Ludwig classification and details the hair growth cycle but provides no new clinical results.

In this case report, a 27-year-old woman with female pattern baldness experienced reduced hair fall and improved hair density after six months of individualized homeopathic treatment, supported by lifestyle guidance at Dr Batra’s® Homeopathy Clinic, with sustained benefits observed over an additional eight-month follow-up period.

In this case report, long-term classical homeopathic management of a woman with advanced female pattern baldness led to significant hair stabilization, improved scalp health, increased hair density, and notable psychosocial benefits, despite previous treatment failures.

In this study of women with androgenetic alopecia, researchers found no significant correlation between migraine occurrence and hair loss severity, although a significant relationship was observed between hair loss severity and pain intensity in those with migraine.

This promotional content from Fort Lauderdale Surgical Hair Restoration advises against certain hair restoration methods but provides no research findings or clinical results; readers are encouraged to call for more information.

Results are not reported for this review, which aimed to gather evidence on the effect of platelet-rich plasma monotherapy for androgenetic alopecia in men and women.

This study suggests that the AR/EDA2R locus may contribute to early-onset female pattern hair loss, but no association was found with the 20p11 locus.

Women with thinning hair have thinner hair strands than women without hair loss.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

This study found that women with common baldness treated with cyclical antiandrogen therapy for 52 weeks experienced increased hair density and a higher percentage of hairs in the anagen growth phase.

This study concluded that minoxidil in various formulations is effective for female pattern hair loss, generally safe, but may cause minor skin irritation, with the foam showing the fewest adverse effects.

This study found no support for the idea that male-pattern baldness in female-to-male transsexuals indicates an increased risk of coronary heart disease through androgenic effects on classic risk factors.

This article presents a classification system for stages of female-pattern androgenetic alopecia to aid early diagnosis and mentions existing systems for rare male-pattern cases, but reports no new clinical results.

This survey reported that Americans often view hair loss as affecting their attractiveness and consider hair transplantation a valuable option, with women willing to pay more than men despite being less likely to undergo the procedure.

This study found no significant differences in sex-hormone binding globulin and androgen serum levels between women with stage II androgenetic alopecia and controls, suggesting that genetically-determined androgen sensitivity might play a major role in the condition.

This article discusses the importance of recognizing adverse drug reactions, methods of prevention, and encourages reporting them to the FDA's MedWatch program; it reports no new results.

This case study will explore Minoxidil's effectiveness and cost-efficiency in treating different types of baldness, without providing new clinical findings.

This paper reviews Minoxidil's use for baldness treatment but reports no new findings; it also raises questions on its efficacy, permanence, cost-effectiveness, demographic benefit, and potential adverse effects.

This article revisits the genetics of pattern baldness but reports no new clinical findings.

Different women have various natural hairline shapes, and understanding this is important for designing hair transplants.

This review covers female pattern hair loss, outlining its progression, existing treatments like topical minoxidil and laser therapy, and notes that anti-androgen therapies need further investigation.

EfficientNet improves accuracy in diagnosing hair loss stages.

This study introduced the BASP classification, a new system for categorizing pattern hair loss in both men and women, and applied it to analyze 2213 Korean subjects.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

This study found that women with female pattern baldness had a marked increase in the 3α,17β-androstanediol glucuronide/sex hormone binding globulin ratio and low serum sex hormone binding globulin.